Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors (MYTHIC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04855656 |
|
Recruitment Status :
Recruiting
First Posted : April 22, 2021
Last Update Posted : April 15, 2024
|
Sponsor:
Repare Therapeutics
Collaborator:
Debiopharm International SA
Information provided by (Responsible Party):
Repare Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2026 |
| Estimated Study Completion Date : | December 31, 2026 |